Peroxisomal and mitochondrial status of two murine oligodendrocytic cell lines (158N, 158JP): Potential models for the study of peroxisomal disorders associated with dysmyelination processes

Journal of Neurochemistry

Volumn 111, Issue 1, 2009, Pages 119-131

  Baarine, Mauhamad ^a,b   Ragot, Kevin ^a,b   Genin, Emmanuelle C ^a,b   El Hajj, Hammam ^a,b   Trompier, Doriane ^a,b   Andreoletti, Pierre ^a,b   Ghandour, M Said ^c   Menetrier, Franck ^a   Cherkaoui Malki, Mustapha ^a,b   Savary, Stephane ^a,b   Lizard, Gerard ^a,b,d  

^a INSERM   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c Université de Strasbourg Faculté de Psychologie   (France)

^d Chu   (France)

Author keywords

Mitochondria; Murine oligodendrocytes; Myelin; Peroxisome

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; 4 PHENYLBUTYRIC ACID; ABC TRANSPORTER; CATALASE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PROTEOLIPID PROTEIN; REACTIVE OXYGEN METABOLITE;

ADRENOLEUKODYSTROPHY; ARTICLE; BRAIN MITOCHONDRION; CELL LINE; DISEASE ASSOCIATION; ELECTRON MICROSCOPY; ENZYME ACTIVITY; FATTY ACID OXIDATION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; MUTATION; MYELINATION; NONHUMAN; OLIGODENDROGLIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UPREGULATION; WESTERN BLOTTING;

MURINAE;

EID: 70349197547     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06311.x     Document Type: Article

References (53)

1. Bass D. A., Parce J. W., Dechatelet L. R., Szejda P., Seeds M. C. Thomas M. (1983) Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J. Immunol. 130, 1910 1917.
2. Baumann N. Pham-Dinh D. (2001) Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol. Rev. 81, 871 927.
3. Berger J. Gartner J. (2006) X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects. Biochim. Biophys. Acta 1763, 1721 1732.
4. Bongarzone E. R., Foster L. M., Byravan S., Schonmann V. Campagnoni A. T. (1997) Temperature-dependent regulation of PLP/DM20 and CNP gene expression in two conditionally-immortalized jimpy oligodendrocyte cell lines. Neurochem. Res. 22, 363 372.
5. Bongarzone E. R., Jacobs E., Schonmann V., Kampf K., Campagnoni C. W. Campagnoni A. T. (2001) Differential sensitivity in the survival of oligodendrocyte cell lines to overexpression of myelin proteolipid protein gene products. J. Neurosci. Res. 65, 485 492.
6. Boucher S. E., Cypher M. A., Carlock L. R. Skoff R. P. (2002) Proteolipid protein gene modulates viability and phenotype of neurons. J. Neurosci. 22, 1772 1783.
7. Buntinx M., Vanderlocht J., Hellings N., Vandenabeele F., Lambrichts I., Raus J., Ameloot M., Stinissen P. Steels P. (2003) Characterization of three human oligodendroglial cell lines as a model to study oligodendrocyte injury: morphology and oligodendrocyte-specific gene expression. J. Neurocytol. 32, 25 38.
8. Campagnoni A. T. Skoff R. P. (2001) The pathobiology of myelin mutants reveal novel biological functions of the MBP and PLP genes. Brain Pathol. 11, 74 91.
9. Cerghet M., Bessert D. A., Nave K. A. Skoff R. P. (2001) Differential expression of apoptotic markers in jimpy and in Plp overexpressors: evidence for different apoptotic pathways. J. Neurocytol. 30, 841 855.
10. Clements C. S., Reid H. H., Beddoe T., Tynan F. E., Perugini M. A., Johns T. G., Bernard C. C. Rossjohn J. (2003) The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis. Proc. Natl Acad. Sci. USA 100, 11059 11064.
11. Eichler F. van Haren K. (2007) Immune response in leukodystrophies. Pediatr. Neurol. 37, 235 244.
12. Feutz A. C., Bellomi I., Allinquant B., Schladenhaufen Y. Ghandour M. S. (1995) Isolation and characterization of defective jimpy oligodendrocytes in culture. J. Neurocytol. 24, 865 877.
13. Feutz A. C., Pham-Dinh D., Allinquant B., Miehe M. Ghandour M. S. (2001) An immortalized jimpy oligodendrocyte cell line: defects in cell cycle and cAMP pathway. Glia 34, 241 252.
14. Forss-Petter S., Werner H., Berger J., Lassmann H., Molzer B., Schwab M. H., Bernheimer H., Zimmermann F. Nave K. A. (1997) Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice. J. Neurosci. Res. 50, 829 843.
15. Fouquet F., Zhou J. M., Ralston E., Murray K., Troalen F., Magal E., Robain O., Dubois-Dalcq M. Aubourg P. (1997) Expression of the adrenoleukodystrophy protein in the human and mouse central nervous system. Neurobiol Dis. 3, 271 285.
16. Fourcade S., López-Erauskin J., Galino J. et al. (2008) Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy. Hum. Mol. Genet. 17, 1762 1773.
17. Ghandour S., Feutz A. C., Jalabi W., Taleb O., Bessert D., Cypher M., Carlock L. Skoff R. P. (2002) Trafficking of PLP/DM20 and cAMP signalling in immortalized jimpy oligodendrocytes. Glia 40, 300 311.
18. Gondcaille C., Depreter M., Fourcade S. et al. (2005) Phenylbutyrate up-regulates the adrenoleukodystrophy-related gene as a nonclassical peroxisome proliferator. J. Cell Biol. 169, 93 104.
19. Harauz G., Ishiyama N., Hill C., Bates I. R., Libich D. S. Farès C. (2004) Myelin basic protein-diverse conformational states of an intrinsically unstructured protein and its roles in myelin assembly and multiple sclerosis. Micron 35, 503 542.
20. Hashimoto T. (1987) Comparison of enzymes of lipid β-oxidation in peroxisomes and mitochondria, in Peroxisome in Biology and Medicine (Fahimi D. H. Sies H., eds pp. 97 105. Springer-Verlag, Heidelberg.
21. Hein S., Schönfeld P., Kahlert S. Reiser G. (2008) Toxic effects of X-linked adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture. Hum. Mol. Genet. 17, 1750 1761.
22. Hörster F., Surtees R. Hoffmann G. F. (2005) Disorders of intermediary metabolism: toxic leukoencephalopathies. J. Inherit. Metab. Dis. 28, 345 356.
23. Huin C., Schohn H., Hatier R., Bentejac M., Antunes L., Plénat F., Bugaut M. Dauça M. (2002) Expression of peroxisome proliferator- activated receptors alpha and gamma in differentiating human colon carcinoma Caco-2 cells. Biol. Cell 94, 15 27.
24. Hulshagen L., Krysko O., Bottelbergs A., Huyghe S., Klein R., Van Veldhoven P. P., de Deyn P. P., d'Hooge R., Hartmann D. Baes M. (2008) Absence of functional peroxisomes from mouse CNS causes dysmyelination and axon degeneration. J. Neurosci. 28, 4015 4027.
25. Jia Z., Pei Z., Li Y., Wei L., Smith K. D. Watkins P. A. (2004) X-linked adrenoleukodystrophy: role of very long-chain acyl-CoA synthetases. Mol. Genet. Metab. 83, 117 127.
26. Kassmann C., Lappe-Siefke C., Baes M. et al. (2007) Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat. Genet. 39, 969 976.
27. Kemp S. Wanders R. J. (2007) X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment. Mol. Genet. Metab. 90, 268 276.
28. Kemp S., Wei H. M., Lu J. F., Braiterman L. T., McGuinness M. C., Moser A. B., Watkins P. A. Smith K. D. (1998) Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophy. Nat. Med. 4, 1261 1268.
29. Koeppen A. H. Robitaille Y. (2002) Pelizaeus-Merzbacher disease. J. Neuropathol. Exp. Neurol. 61, 747 759.
30. Lizard G., Chignol M. C., Souchier S., Schmitt D. Chardonnet Y. (1994) Laser scanning confocal microscopy and quantitative microscopy with a charge coupled device camera improve detection of human papillomavirus DNA revealed by fluorescence in situ hybridization. Histochemistry 101, 303 310.
31. Lizard G., Gueldry S., Sordet O., Monier S., Athias A., Miguet C., Bessede G., Lemaire S., Solary E. Gambert P. (1998) Glutathione is implied in the control of 7-ketocholesterol-induced apoptosis, which is associated with radical oxygen species production. FASEB J. 12, 1651 1663.
32. Macklin W., Gardinier M., King K. Kampf K. (1987) An AG→CG transition at a splice site in the myelin proteolipid protein gene in jimpy mice results in the removal of an exon. FEBS Lett. 2, 417 421.
33. Miguet C., Monier S., Bettaieb A., Athias A., Bessède G., Laubriet A., Lemaire S., Néel D., Gambert P. Lizard G. (2001) Ceramide generation occuring during 7β-hydroxycholesterol- and 7-ketocholesterol-induced apoptosis is caspase independent and is not required to trigger cell death. Cell Death Differ. 8, 83 99.
34. Nguyen S. D., Baes M. Van Veldhoven P. P. (2008) Degradation of very long chain dicarboxylic polyunsaturated fatty acids in mouse hepatocytes, a peroxisomal process. Biochim. Biophys. Acta 1781, 400 405.
35. Oaxaca-Castillo D., Andreoletti P., Vluggens A., Yu S., van Veldhoven P. P., Reddy J. K. Cherkaoui-Malki M. (2007) Biochemical characterization of two functional human liver acyl-CoA oxidase isoforms 1a and 1b encoded by a single gene. Biochem. Biophys. Res. Commun. 360, 314 319.
36. Paintlia A. S., Gilg A. G., Khan M., Singh A. K., Barbosa E. Singh I. (2003) Correlation of very long chain fatty acid accumulation and inflammatory disease progression in childhood X-ALD: implications for potential therapies. Neurobiol. Dis. 14, 425 439.
37. Poll-The B. T., Roels F., Ogier H. et al. (1988) A new peroxisomal disorder with enlarged peroxisomes and a specific deficiency of acyl-CoA oxidase (pseudo-neonatal adrenoleukodystrophy). Am. J. Hum. Genet. 42, 422 434.
38. Ratinaud M. H., Leprat P. Julien R. (1988) In situ flow cytometric analysis of nonyl acridine orange-stained mitochondria from splenocytes. Cytometry 9, 206 212.
39. Rothe G. Valet G. (1990) Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2′,7′- dichlorofluorescin. J. Leukoc. Biol. 47, 440 448.
40. Santos M. J., Henderson S. C., Moser A. B., Moser H. W. Lazarow P. B. (2000) Peroxisomal ghosts are intracellular structures distinct from lysosomal compartments in Zellweger syndrome: a confocal laser scanning microscopy study. Biol. Cell 92, 85 94.
41. Schrader M. Fahimi H. D. (2006) Peroxisomes and oxidative stress. Biochim. Biophys. Acta 1763, 1755 1766.
42. Schrader M. Fahimi D. (2008) The peroxisome: still a mysterious organelle. Histochem. Cell Biol. 129, 421 440.
43. Schrader M., Baumgart E., Völkl A. Fahimi H. D. (1994) Heterogeneity of peroxisomes in human hepatoblastoma cell line HepG2. Evidence of distinct subpopulations. Eur. J. Cell Biol. 64, 281 294.
44. Schumann U. Subramani S. (2008) Special delivery from mitochondria to peroxisomes. Trends Cell Biol. 18, 253 256.
45. Skoff R. P., Bessert D. A., Cerghet M., Franklin M. J., Rout U. K., Nave K. A., Carlock L., Ghandour M. S. Armant D. R. (2004) The myelin proteolipid protein gene modulates apoptosis in neural and non-neural tissues. Cell Death Differ. 11, 1247 1257.
46. Sprinkle T. J. (1989) 2′,3′-Cyclic nucleotide 3′-phosphodiesterase, an oligodendrocyte-Schwann cell and myelin-associated enzyme of the nervous system. Crit. Rev. Neurobiol. 4, 235 301.
47. Steinman L. (2008) Nuanced roles of cytokines in three major human brain disorders. J. Clin. Invest. 118, 3557 3563.
48. Suzuki Y., Shimozawa N., Yajima S. et al. (1994) Novel subtype of peroxisomal Acyl-CoA oxidase deficiency and bifunctional enzyme deficiency with detectable enzyme protein: identification by means of complementation analysis. Am. J. Hum. Genet. 54, 36 43.
49. Taylor C. M., Marta C. B., Claycomb R. J., Han D. K., Rasband M. N., Coetzee T. Pfeiffer S. E. (2004) Proteomic mapping provides powerful insights into functional myelin biology. Proc. Natl Acad. Sci. USA 101, 4643 4648.
50. Verity A. M., Bredesen D., Vonderscher C., Handeley V. W. Campagnoni A. T. (1993) Expression of myelin protein genes and other myelin components in an oligodendrocytic cell line conditionally immortalized with a temperature-sensitive retrovirus. J. Neurochem. 60, 577 587.
51. Wanders R. J. Waterham H. R. (2006a) Biochemistry of mammalian peroxisomes revisited. Annu. Rev. Biochem. 75, 295 332.
52. Wanders R. J. Waterham H. R. (2006b) Peroxisomal disorders: the single peroxisomal enzyme deficiencies. Biochim. Biophys. Acta 1763, 1707 1720.
53. Zhou L. Griffin J. W. (2003) Demyelinating neuropathies. Curr. Opin. Neurol. 16, 307 313.